Merck : MRK

All Merck Articles

1088 Articles

Drew Wood | May 8, 2026 at 8:29 AM EDT

A $1.5 Million Portfolio That Quietly Pays You $83,400 a Year, No Job Required

An $83,400 annual paycheck sits comfortably above the U.S. median household income of roughly $80,610. Replacing that income with a…

Austin Smith | May 7, 2026 at 5:24 PM EDT

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

Schwab U.S. Dividend Equity ETF (NYSEARCA: SCHD) and Vanguard High Dividend Yield ETF (NYSEARCA: VYM) sit on most income investors’…

Vandita Jadeja | May 6, 2026 at 10:32 AM EDT

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest…

Lee Jackson | May 6, 2026 at 7:51 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and More

Pre-Market Stock Futures: Futures are trading higher on Wednesday as news of an impending end to the Iran war is…

Vandita Jadeja | May 5, 2026 at 1:17 PM EDT

Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds

Merck (NYSE:MRK | MRK Price Prediction) delivered its fourth consecutive earnings beat, but shares slipped on the earnings report. With…

Lee Jackson | May 4, 2026 at 7:44 AM EDT

Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5

The “Dogs of the Dow” is a well-known strategy first published in 1991 by Michael O’Higgins. The plan aims to…

Gerelyn Terzo | Apr 30, 2026 at 9:09 AM EDT

S&P 500 Rides Tech Earnings Wave Despite Inflation Warning Shot

The S&P 500 (^GSPC) is off to the races this morning, up 0.50% thanks to tailwinds from mega-cap earnings beats…

Rich Duprey | Apr 15, 2026 at 11:08 AM EDT

Here’s Why I Can’t Stop Buying This Dividend Growth Dynamo

The data shows SCHD has become a notable anchor holding for long-term dividend-focused portfolios, and after looking at the numbers,…

Trey Thoelcke | Apr 7, 2026 at 10:05 AM EDT

Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought?

Two stocks retirement investors typically reach for in uncertain markets have risen notably in recent months. Costco Wholesale (NASDAQ: COST…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT),…

Michael Williams | Mar 25, 2026 at 10:45 AM EDT

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

The S&P 500 you own through a standard index fund is not as diversified as it looks. The cap-weighted version…

Lee Jackson | Mar 18, 2026 at 7:19 AM EDT

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on…

Austin Smith | Mar 16, 2026 at 9:00 AM EDT

This Schwab ETF Holds 100 Dividend Stocks, Charges $6 a Year, and Yields More Than Most Savings Accounts

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) costs $6 a year on a $10,000 investment, holds 100 dividend stocks, and currently…

Joel South | Mar 12, 2026 at 11:14 AM EDT

Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150

Merck & Co., Inc. (NYSE:MRK | MRK Price Prediction) has been on a strong recovery run, gaining 23% over the…

1 2 3 4 … 73

Merck : MRK

All Merck Articles

A $1.5 Million Portfolio That Quietly Pays You $83,400 a Year, No Job Required

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and More

Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds

Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5

S&P 500 Rides Tech Earnings Wave Despite Inflation Warning Shot

Here’s Why I Can’t Stop Buying This Dividend Growth Dynamo

Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought?

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

This Schwab ETF Holds 100 Dividend Stocks, Charges $6 a Year, and Yields More Than Most Savings Accounts

Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

3 Reasons I’m Buying Amazon Over and Over Until Late 2026

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

Merck : MRK

All Merck Articles

A $1.5 Million Portfolio That Quietly Pays You $83,400 a Year, No Job Required

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and More

Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds

Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5

S&P 500 Rides Tech Earnings Wave Despite Inflation Warning Shot

Here’s Why I Can’t Stop Buying This Dividend Growth Dynamo

Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought?

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

This Schwab ETF Holds 100 Dividend Stocks, Charges $6 a Year, and Yields More Than Most Savings Accounts

Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

3 Reasons I’m Buying Amazon Over and Over Until Late 2026

Featured Reads

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This